Clinical trial

Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure

NCT00400985

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-01-01

PhaseNA

Study timeline

Study start (unknown)2005-01-01Date precision: month

Registry last updated2025-07-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure, Congestiveunresolved

Interventions

Implantable device: monitoring of intrathoracic impedance using the OptiVol diagnostic tool.DEVICE

Sponsors & collaborators

Medtronic Cardiac Rhythm and Heart Failurelead sponsor

Medtroniccollaborator

Mapped research locations

LondonUnited Kingdom1 AntwerpBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00400985 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.